π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Rhinitis is a type of upper respiratory infection with a common nasal patho...
Status
Completed
Location
Thai Binh University of Medicine and Pharmacy
Start Date
2022-09-26
Trial ID
NCT05984004
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GL...
Status
Completed
Location
Klinisk Institut, Afd. MEA, Aarhus Sygehus, NBG
Start Date
2011-05
Trial ID
NCT01333163
Treatments Being Tested
To investigate safety, tolerability, pharmacokinetics, pharmacodynamics and...
Status
Completed
Location
Fukuoka Clinical Site
Start Date
2019-09-12
Trial ID
NCT04079062
Treatments Being Tested
To evaluate whether PF-02545920 reduces the effects of ketamine on brain ac...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2011-04
Trial ID
NCT01244880
Treatments Being Tested
This study is a single center, randomized, open/double-blind, placebo-contr...
Status
Unknown
Location
Huashan Hospital Fudan University
Start Date
2024-03-12
Trial ID
NCT06285227
Treatments Being Tested
This study will test the hypotheses that a single dose of oxyntomodulin (OX...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01055340
This is a Phase 1, randomized, double-blind, placebo-controlled, first-in-h...
Status
Completed
Location
HLB Science
Start Date
2023-07-24
Trial ID
NCT07347223
Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Status
Completed
Location
Ppd Development
Start Date
2007-12
Trial ID
NCT00569803
Treatments Being Tested
A Dose Escalating Study of PRS-060 Administered by Oral Inhalation or IV In...
Status
Completed
Location
Nucleus Network Limited
Start Date
2017-12-08
Trial ID
NCT03384290